tiprankstipranks
Trending News
More News >
Shield Therapeutics (DE:1JS)
:1JS

Shield Therapeutics (1JS) Revenue

Compare
2 Followers

Shield Therapeutics Revenue

Shield Therapeutics had a revenue of 15.53M in the quarter ending Dec 31, 2024, with 61.92%. This bring the company's revenue in the last twelve months to 25.12M, Decreased 51.56%. In the fiscal year ending Dec 31, 2024, Shield Therapeutics had annual revenue of 25.18M with 92.46% growth.
Revenue (ttm)
25.12M
Revenue Growth
P/S Ratio
1.17
Revenue/Employee
€399,741
Employees
63
Market Cap
€29.50M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
25.18M12.10M+92.46%
Dec 31, 2023
13.09M8.62M+192.93%
Dec 31, 2022
4.47M2.95M+194.08%
Dec 31, 2021
1.52M-8.87M-85.38%
Dec 31, 2020
10.39M9.67M+1,344.65%
Dec 31, 2019
719.00K-11.16M-93.95%
Dec 31, 2018
11.88M11.24M+1,765.15%
Dec 31, 2017
637.00K333.00K+109.54%
Dec 31, 2016
304.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis